Home
RLYB
RLYB News

Latest Rallybio Corporation (RLYB) News on June 28, 2025

Rallybio Initiates Dosing in RLYB116 Phase 1 Confirmatory Pharmacokinetic/Pharmacodynamic Study

Business Wire

16 days ago

Rallybio Initiates Dosing in RLYB116 Phase 1 Confirmatory Pharmacokinetic/Pharmacodynamic Study

Rallybio Reports First Quarter 2025 Financial Results and Provides Business Updates

Business Wire

2 months ago

Rallybio Reports First Quarter 2025 Financial Results and Provides Business Updates

Rallybio to Present at the 2025 Citizens JMP Life Sciences Conference

Business Wire

2 months ago

Rallybio to Present at the 2025 Citizens JMP Life Sciences Conference

MT Newswires

2 months ago

Evercore ISI Downgrades Rallybio to In Line From Outperform

RLYB Ends Pregnancy-Related Rare Disease Program, Stock Tanks

Zacks

3 months ago

RLYB Ends Pregnancy-Related Rare Disease Program, Stock Tanks

MT Newswires

3 months ago

HC Wainwright Downgrades Rallybio to Neutral From Buy

Rallybio drops drug for rare maternal disorder following Phase II fail

Clinical Trials Arena

3 months ago

Rallybio drops drug for rare maternal disorder following Phase II fail

MT Newswires

3 months ago

Rallybio Terminates RLYB212 Development for Rare Immune Disorder; Shares Fall

Rallybio to Discontinue Development of RLYB212 for Prevention of FNAIT

Business Wire

3 months ago

Rallybio to Discontinue Development of RLYB212 for Prevention of FNAIT

Rallybio discontinues lead drug for rare maternal disorder

BioPharma Dive

3 months ago

Rallybio discontinues lead drug for rare maternal disorder

Rallybio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates

Business Wire

4 months ago

Rallybio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates

Is Rallybio (NASDAQ:RLYB) In A Good Position To Deliver On Growth Plans?

Simply Wall St.

4 months ago

Is Rallybio (NASDAQ:RLYB) In A Good Position To Deliver On Growth Plans?

Rallybio to Present at the TD Cowen 45th Annual Health Care Conference

Business Wire

4 months ago

Rallybio to Present at the TD Cowen 45th Annual Health Care Conference

Rallybio doses first subject in Phase II trial of treatment for FNAIT in Europe

Clinical Trials Arena

5 months ago

Rallybio doses first subject in Phase II trial of treatment for FNAIT in Europe

Rallybio Announces Initiation of Dosing in RLYB212 Phase 2 Clinical Trial

Business Wire

5 months ago

Rallybio Announces Initiation of Dosing in RLYB212 Phase 2 Clinical Trial

Rallybio Highlights 2024 Accomplishments and Anticipated Milestones for 2025

Business Wire

6 months ago

Rallybio Highlights 2024 Accomplishments and Anticipated Milestones for 2025

US Penny Stocks To Consider In December 2024

Simply Wall St.

7 months ago

US Penny Stocks To Consider In December 2024

Rallybio Announces Promising RLYB212 and RLYB332 Preclinical Data at the 66th American Society of Hematology Annual Meeting

Business Wire

7 months ago

Rallybio Announces Promising RLYB212 and RLYB332 Preclinical Data at the 66th American Society of Hematology Annual Meeting

Rallybio price target lowered to $7 from $8 at JMP Securities

TipRanks

7 months ago

Rallybio price target lowered to $7 from $8 at JMP Securities

Rallybio to Initiate RLYB116 Confirmatory Clinical PK/PD Study in Second Quarter 2025

Business Wire

7 months ago

Rallybio to Initiate RLYB116 Confirmatory Clinical PK/PD Study in Second Quarter 2025

Rallybio Announces Publication of Target-Mediated Drug Disposition Modeling and Simulations Informing the RLYB212 Dosing Regimen in Pregnant Women

Business Wire

7 months ago

Rallybio Announces Publication of Target-Mediated Drug Disposition Modeling and Simulations Informing the RLYB212 Dosing Regimen in Pregnant Women

Rallybio to Present at the 2024 Evercore ISI HealthCONx Conference

Business Wire

7 months ago

Rallybio to Present at the 2024 Evercore ISI HealthCONx Conference

Rallybio to Provide Update on RLYB116 Program, an Innovative Subcutaneously Injected C5 Inhibitor

Business Wire

7 months ago

Rallybio to Provide Update on RLYB116 Program, an Innovative Subcutaneously Injected C5 Inhibitor

Rallybio commences Phase II trial of RLYB212 for FNAIT in pregnant women

Clinical Trials Arena

7 months ago

Rallybio commences Phase II trial of RLYB212 for FNAIT in pregnant women

Rallybio Announces Initiation of Phase 2 Clinical Trial of RLYB212

Business Wire

7 months ago

Rallybio Announces Initiation of Phase 2 Clinical Trial of RLYB212

3 US Penny Stocks With Market Caps Over $40M To Consider

Simply Wall St.

7 months ago

3 US Penny Stocks With Market Caps Over $40M To Consider

Rallybio Reports Third Quarter 2024 Financial Results and Provides Business Updates

Business Wire

8 months ago

Rallybio Reports Third Quarter 2024 Financial Results and Provides Business Updates

Two former Alexion leaders fight through layoffs and a tough market to maintain a rare disease biotech

Pharma Voice

8 months ago

Two former Alexion leaders fight through layoffs and a tough market to maintain a rare disease biotech

MT Newswires

8 months ago

Rallybio Gets Clearance for Phase 2 Alloimunization Study in Europe, UK

Rallybio Announces Approval of Clinical Trial Applications for Phase 2 Trial of RLYB212 in Pregnant Women at Higher Risk of Alloimmunization and FNAIT

Business Wire

8 months ago

Rallybio Announces Approval of Clinical Trial Applications for Phase 2 Trial of RLYB212 in Pregnant Women at Higher Risk of Alloimmunization and FNAIT

Data Demonstrating ENPP1 Inhibition as a Therapeutic Approach for Later-onset Hypophosphatasia Presented at the American Society for Bone and Mineral Research 2024 Annual Meeting

Business Wire

9 months ago

Data Demonstrating ENPP1 Inhibition as a Therapeutic Approach for Later-onset Hypophosphatasia Presented at the American Society for Bone and Mineral Research 2024 Annual Meeting

Rallybio to Present Results of Epidemiological Analysis Demonstrating FNAIT Risk Across Racially and Ethnically Diverse Populations at the American Society of Human Genetics 2024 Annual Meeting

Business Wire

9 months ago

Rallybio to Present Results of Epidemiological Analysis Demonstrating FNAIT Risk Across Racially and Ethnically Diverse Populations at the American Society of Human Genetics 2024 Annual Meeting

Rallybio to Present Results of Epidemiological Analysis Demonstrating FNAIT Risk Across Racially and Ethnically Diverse Populations at the NORD Breakthrough Summit

Business Wire

10 months ago

Rallybio to Present Results of Epidemiological Analysis Demonstrating FNAIT Risk Across Racially and Ethnically Diverse Populations at the NORD Breakthrough Summit

Fierce Names Rallybio to the 2024 Fierce 50 List as an Innovation Honoree

Business Wire

10 months ago

Fierce Names Rallybio to the 2024 Fierce 50 List as an Innovation Honoree

Rallybio Announces Publication of RLYB212 Phase 1 Proof-of-Concept Study Results in Thrombosis and Haemostasis

Business Wire

10 months ago

Rallybio Announces Publication of RLYB212 Phase 1 Proof-of-Concept Study Results in Thrombosis and Haemostasis

Rallybio to Present at Upcoming Investor Conferences

Business Wire

10 months ago

Rallybio to Present at Upcoming Investor Conferences

Rallybio (RLYB) Upgraded to Buy: What Does It Mean for the Stock?

Zacks

10 months ago

Rallybio (RLYB) Upgraded to Buy: What Does It Mean for the Stock?

Is Rallybio (NASDAQ:RLYB) In A Good Position To Invest In Growth?

Simply Wall St.

a year ago

Is Rallybio (NASDAQ:RLYB) In A Good Position To Invest In Growth?

Rallybio Reports Second Quarter 2024 Financial Results and Provides Business Updates

Business Wire

a year ago

Rallybio Reports Second Quarter 2024 Financial Results and Provides Business Updates

Rallybio to Present at the 2024 Jones Healthcare Seaside Summit

Business Wire

a year ago

Rallybio to Present at the 2024 Jones Healthcare Seaside Summit

Rallybio Announces Results of Epidemiological Analysis Demonstrating FNAIT Risk Across Racially and Ethnically Diverse Populations

Business Wire

a year ago

Rallybio Announces Results of Epidemiological Analysis Demonstrating FNAIT Risk Across Racially and Ethnically Diverse Populations

NexTech Solutions Has Agreed to Acquire Rome Research Corporation to Expand Service Offerings and Enhance Mission Support Capabilities

PR Newswire

a year ago

NexTech Solutions Has Agreed to Acquire Rome Research Corporation to Expand Service Offerings and Enhance Mission Support Capabilities

Business Wire

a year ago

Form 8.3 - International Distribution Services plc

Business Wire

a year ago

Form 8.3 - Darktrace plc

US Supreme Court rejects Kroger challenge to Grubhub trademark win

Reuters

a year ago

US Supreme Court rejects Kroger challenge to Grubhub trademark win

Dow Jones Falls As AMD Slides On Downgrade; Nvidia Stock Split Takes Effect

Investor's Business Daily

a year ago

Dow Jones Falls As AMD Slides On Downgrade; Nvidia Stock Split Takes Effect

GlobeNewswire

a year ago

Middlefield Canadian Income PCC: Net Asset Value(s)

GoldATM Supports Growing Consumer Demand for Gold Purchase with New ATMs in North Carolina

Business Wire

a year ago

GoldATM Supports Growing Consumer Demand for Gold Purchase with New ATMs in North Carolina

Business Wire

a year ago

Form 8.3 - International Paper Company

Rallybio Reports First Quarter 2024 Financial Results and Provides Business Updates

Business Wire

a year ago

Rallybio Reports First Quarter 2024 Financial Results and Provides Business Updates

Rallybio to Present at the 2024 Citizens JMP Life Sciences Conference

Business Wire

a year ago

Rallybio to Present at the 2024 Citizens JMP Life Sciences Conference

FNAIT Systematic Literature Review and Meta-Analysis Presented at the Academy of Managed Care Pharmacy 2024 Annual Meeting

Business Wire

a year ago

FNAIT Systematic Literature Review and Meta-Analysis Presented at the Academy of Managed Care Pharmacy 2024 Annual Meeting

RallyBio (RLYB) Partners With J&J & Gets $6.6M Funding, Stock Up

Zacks

a year ago

RallyBio (RLYB) Partners With J&J & Gets $6.6M Funding, Stock Up

Rallybio Announces Collaboration to Advance Therapeutic Solutions for Pregnant Individuals at Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)

Business Wire

a year ago

Rallybio Announces Collaboration to Advance Therapeutic Solutions for Pregnant Individuals at Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)

J&J, Rallybio partner on drug development for rare fetal condition

BioPharma Dive

a year ago

J&J, Rallybio partner on drug development for rare fetal condition

Rallybio Announces FNAIT Systematic Literature Review to be Presented at the AMCP 2024 Annual Meeting

Business Wire

a year ago

Rallybio Announces FNAIT Systematic Literature Review to be Presented at the AMCP 2024 Annual Meeting

Rallybio Reports Fourth Quarter and Full Year 2023 Financial Results

Business Wire

a year ago

Rallybio Reports Fourth Quarter and Full Year 2023 Financial Results

Rallybio to Present at the TD Cowen 44th Annual Health Care Conference

Business Wire

a year ago

Rallybio to Present at the TD Cowen 44th Annual Health Care Conference

Rallybio Announces Portfolio Prioritization and Provides Corporate Update

Business Wire

a year ago

Rallybio Announces Portfolio Prioritization and Provides Corporate Update

Business Wire

a year ago

M-tron Industries Announces the Creation of Strategic Committee

Investing in Landmark Bancorp (NASDAQ:LARK) five years ago would have delivered you a 39% gain

Simply Wall St.

a year ago

Investing in Landmark Bancorp (NASDAQ:LARK) five years ago would have delivered you a 39% gain

Here's Why Lifetime Brands (LCUT) Gained But Lagged the Market Today

Zacks

a year ago

Here's Why Lifetime Brands (LCUT) Gained But Lagged the Market Today

Is Rallybio (NASDAQ:RLYB) In A Good Position To Deliver On Growth Plans?

Simply Wall St.

a year ago

Is Rallybio (NASDAQ:RLYB) In A Good Position To Deliver On Growth Plans?

Tenaya Therapeutics, Inc. (TNYA) Upgraded to Strong Buy: Here's Why

Zacks

a year ago

Tenaya Therapeutics, Inc. (TNYA) Upgraded to Strong Buy: Here's Why

Business Wire

a year ago

MtronPTI to Present at the Microcap Conference in Atlantic City

Hanover Bancorp, Inc. Reports Earnings for the Fourth Calendar Quarter highlighted by Increased Net Income and Net Interest Income and Strong Non-interest Income

GlobeNewswire

a year ago

Hanover Bancorp, Inc. Reports Earnings for the Fourth Calendar Quarter highlighted by Increased Net Income and Net Interest Income and Strong Non-interest Income

Is Manitex International, Inc. (NASDAQ:MNTX) Trading At A 49% Discount?

Simply Wall St.

a year ago

Is Manitex International, Inc. (NASDAQ:MNTX) Trading At A 49% Discount?

Canoo Reaches Agreement with U.S. Postal Service for Purchase of Electric Vehicles

GlobeNewswire

a year ago

Canoo Reaches Agreement with U.S. Postal Service for Purchase of Electric Vehicles

Spotting Winners: Zevia PBC (NYSE:ZVIA) And Beverages and Alcohol Stocks In Q3

StockStory

a year ago

Spotting Winners: Zevia PBC (NYSE:ZVIA) And Beverages and Alcohol Stocks In Q3

Is First Business Financial Services (FBIZ) Stock Undervalued Right Now?

Zacks

a year ago

Is First Business Financial Services (FBIZ) Stock Undervalued Right Now?

Vor Bio Doses First AML Patient with VCAR33 (ALLO) and Provides Corporate Update

GlobeNewswire

a year ago

Vor Bio Doses First AML Patient with VCAR33 (ALLO) and Provides Corporate Update

Here's Why You Should Hold Zebra (ZBRA) in Your Portfolio

Zacks

a year ago

Here's Why You Should Hold Zebra (ZBRA) in Your Portfolio

Insider Sell: President William Drafts Sells 9,710 Shares of M-Tron Industries Inc (MPTI)

GuruFocus.com

a year ago

Insider Sell: President William Drafts Sells 9,710 Shares of M-Tron Industries Inc (MPTI)

Heritage Global Partners, New Mill Capital, Federal Equipment Company and Keith Machinery Corp Acquire Pharmaceutical Site from Alkem Laboratories

Business Wire

a year ago

Heritage Global Partners, New Mill Capital, Federal Equipment Company and Keith Machinery Corp Acquire Pharmaceutical Site from Alkem Laboratories

Allurion Announces Publication of Randomized, Double-Blind Study Demonstrating Significant Improvement in Obesity-Related Co-Morbidities

Business Wire

a year ago

Allurion Announces Publication of Randomized, Double-Blind Study Demonstrating Significant Improvement in Obesity-Related Co-Morbidities

Semantix Announces CFO Resignation and Succession Plan

GlobeNewswire

a year ago

Semantix Announces CFO Resignation and Succession Plan

Hyperfine, Inc. Launches AI-powered Brain Imaging Software for Enhanced Image Quality and Ease of Use

Business Wire

a year ago

Hyperfine, Inc. Launches AI-powered Brain Imaging Software for Enhanced Image Quality and Ease of Use

LiveOne (Nasdaq: LVO) Provides Update for Its $10M Stock Repurchase Program

GlobeNewswire

a year ago

LiveOne (Nasdaq: LVO) Provides Update for Its $10M Stock Repurchase Program

Advanced Emissions Solutions Insiders Added US$7.97m Of Stock To Their Holdings

Simply Wall St.

a year ago

Advanced Emissions Solutions Insiders Added US$7.97m Of Stock To Their Holdings

Cartesian Therapeutics Highlights Progress and 2024 Strategic Priorities Across Innovative Pipeline of mRNA Cell Therapies for Autoimmunity

GlobeNewswire

a year ago

Cartesian Therapeutics Highlights Progress and 2024 Strategic Priorities Across Innovative Pipeline of mRNA Cell Therapies for Autoimmunity

Allbirds, Adidas-Backed EVA Recycling Tech Scores $50K in New Funding

Sourcing Journal

a year ago

Allbirds, Adidas-Backed EVA Recycling Tech Scores $50K in New Funding

Virco Manufacturing Corporation (VIRC) Hit a 52 Week High, Can the Run Continue?

Zacks

a year ago

Virco Manufacturing Corporation (VIRC) Hit a 52 Week High, Can the Run Continue?

Augmedix Exits Calendar 2023 with Expected $51 Million in Annual Recurring Revenue

GlobeNewswire

a year ago

Augmedix Exits Calendar 2023 with Expected $51 Million in Annual Recurring Revenue

DocGo CEO Defends Performance on New York City Migrant-Care Contract

The Wall Street Journal

a year ago

DocGo CEO Defends Performance on New York City Migrant-Care Contract

Immix Biopharma Announces Dr. Vaishali Sanchorawala, AL Amyloidosis Thought Leader, Director of the Amyloidosis Center at Boston University and Boston Medical Center, Joins Scientific Advisory Board

GlobeNewswire

a year ago

Immix Biopharma Announces Dr. Vaishali Sanchorawala, AL Amyloidosis Thought Leader, Director of the Amyloidosis Center at Boston University and Boston Medical Center, Joins Scientific Advisory Board

Solid Biosciences to Participate at 42nd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

a year ago

Solid Biosciences to Participate at 42nd Annual J.P. Morgan Healthcare Conference

Rallybio Highlights Portfolio Advances and Outlines Expected Milestones in 2024

Business Wire

a year ago

Rallybio Highlights Portfolio Advances and Outlines Expected Milestones in 2024

P3 Health Partners to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Business Wire

a year ago

P3 Health Partners to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Invesco High Income Trust II, and Invesco Senior Income Trust Declare Dividends

PR Newswire

a year ago

Invesco High Income Trust II, and Invesco Senior Income Trust Declare Dividends

11 Best Psychedelic Stocks to Buy in 2024

Insider Monkey

a year ago

11 Best Psychedelic Stocks to Buy in 2024

16 Most Promising Long-Term Stocks According to Analysts

Insider Monkey

a year ago

16 Most Promising Long-Term Stocks According to Analysts

Profound Medical Announces Proposed Public Offering of Common Shares

GlobeNewswire

2 years ago

Profound Medical Announces Proposed Public Offering of Common Shares

Rallybio Announces Preliminary Phase 1 Multiple Ascending Dose Data for RLYB116, an Innovative Subcutaneously Injected Inhibitor of Complement Component 5

Business Wire

2 years ago

Rallybio Announces Preliminary Phase 1 Multiple Ascending Dose Data for RLYB116, an Innovative Subcutaneously Injected Inhibitor of Complement Component 5

15 Best Falling Stocks To Buy Now

Insider Monkey

2 years ago

15 Best Falling Stocks To Buy Now

Investors in Vuzix (NASDAQ:VUZI) from three years ago are still down 74%, even after 11% gain this past week

Simply Wall St.

2 years ago

Investors in Vuzix (NASDAQ:VUZI) from three years ago are still down 74%, even after 11% gain this past week

SHL Telemedicine and BARMER to Highlight Digital Patient Care at BMC Congress 2024

Business Wire

2 years ago

SHL Telemedicine and BARMER to Highlight Digital Patient Care at BMC Congress 2024

7 Stocks to Buy if You’re Bullish on the Energy Sector

InvestorPlace

2 years ago

7 Stocks to Buy if You’re Bullish on the Energy Sector

3 Stocks to Buy That Are Up 200% or More in 2023

InvestorPlace

2 years ago

3 Stocks to Buy That Are Up 200% or More in 2023

Turtle Beach Unveils Its Groundbreaking VelocityOne Flightdeck – the Ultimate Universal HOTAS Flight Simulation Control System

Business Wire

2 years ago

Turtle Beach Unveils Its Groundbreaking VelocityOne Flightdeck – the Ultimate Universal HOTAS Flight Simulation Control System

GlobeNewswire

2 years ago

UPDATE - AI set to transform eCommerce in Germany as Händlerbund and Rezolve join forces to overhaul traditional model

Share on Social Networks: